REQUEST A DEMO
Total
USD $0.00
Search more companies

Honz Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Honz Pharmaceutical Co., Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The main business includs scientific research production and sales of large pharmaceutical companies. It now has more than 30 Chinese and Western medicines symbol, in which national drug 6, the State Protected Chinese Medicine 1. Rui Zhiqing (nimesulide particles) and orange particles cough is the company's flagship product, Rui Zhiqing market share in its class nation, orange-red particles cough medicine for the country to protect species. The company reported in the research and a class of drugs in one, three new drugs five, six and five drug market prospects of more generic drugs more than 20. The company has focused on the production of child drug research and development in the field of child medicine R & D and production capacity in the domestic leading position. "Hong Chi" brand Chinese and Western medicine loved by the majority of patients, pediatric medicines distributed nationwide Hong Chi brand was named "outstanding Chinese high-tech brand."

Headquarters
6 Yaogu Rd. Yaogu Ind. Pk. Haikou
Haikou; Hainan; Postal Code: 570311

Contact Details: Purchase the Honz Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.honz.com.cn

Basic Information
Total Employees:
Purchase the Honz Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Honz Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Honz Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Honz Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
January 20, 1994
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
27.56%
Purchase this report to view the information.
1.81%
Purchase this report to view the information.
1.71%
Purchase this report to view the information.
1.37%
Purchase this report to view the information.
0.6%
Subsidiaries
Guangdong Kangda Pharmaceutical Marketing Co., Ltd.
100%
Guangdong Yuanning Pharmaceutical Co., Ltd.
100%
Hainan Kangzhi Biological Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Honz Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-40.01%
Total operating revenue
-40.01%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-0.83%
Total equity
-2.43%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
5.56%
Quick Ratio
-0.09%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?